• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BNB Plus Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    3/24/26 4:06:00 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary
    Get the next $BNBX alert in real time by email
    false 0000744452 0000744452 2026-03-20 2026-03-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): March 20, 2026

      

    BNB Plus Corp.

    (Exact name of registrant as specified in its charter)

      

    Delaware

    (State or other jurisdiction

    of incorporation)

    001-36745

    (Commission File Number)

    59-2262718

    (IRS Employer

    Identification No.)

     

    25 Health Sciences Drive

    Stony Brook, New York 11790

    (Address of principal executive offices) (Zip Code)

      

    631-240-8800

    (Registrants’ telephone number, including area code)

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange on which registered
    Common Stock, $0.001 par value   BNBX   The Nasdaq Stock Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company    ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    BNB Plus Corp. (the “Company”) received written notice dated March 20, 2026 (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company no longer satisfies the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of thirty (30) consecutive business days (collectively, the “Bid Price Rule”). Based on the closing bid price of the Company’s common stock, par value $0.001 per share (“Common Stock”), for the thirty (30) consecutive business days from February 5, 2026 to March 19, 2026, the Company no longer satisfies the Bid Price Rule.

      

    The Notification Letter further indicated that, pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for a compliance period under Nasdaq Listing Rule 5810(c)(3)(A) due to the fact that the Company has effected a reverse stock split over the prior one-year period or has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one; accordingly, the Company was informed that its securities will be subject to delisting from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”). Accordingly, the Company intends to timely request a hearing before the Panel, and at which point, such timely request will automatically stay any further suspension or delisting action by Nasdaq at least pending the ultimate conclusion of the hearing process. There can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will be able to regain compliance and thereafter maintain its listing on Nasdaq.

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Current Report on Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the Company’s intent or ability to regain compliance with the Bid Price Rule, the outcome of any Nasdaq hearing and appeal process and the Company’s intent or ability to maintain the Common Stock’s listing on Nasdaq. All forward-looking statements reflect the Company’s beliefs and assumptions only as of the date of this Current Report on Form 8-K. The Company undertakes no obligation to update forward-looking statements to reflect future events or circumstances. Capitalized terms shall have the meanings ascribed to such terms in the Current Report on Form 8-K.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      BNB Plus Corp.
         

    Date: March 24, 2026

    By:   /s/ Clay Shorrock
      Name: Clay Shorrock
      Title: Chief Executive Officer

     

     

    Get the next $BNBX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNBX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BNBX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Haft James

    4 - BNB PLUS CORP. (0000744452) (Issuer)

    2/13/26 4:16:58 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    New insider Haft James claimed ownership of 22,590 shares (SEC Form 3)

    3 - BNB PLUS CORP. (0000744452) (Issuer)

    2/13/26 4:15:32 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    SEC Form 4 filed by Chief Financial Officer Jantzen Beth

    4 - BNB PLUS CORP. (0000744452) (Issuer)

    12/16/25 4:05:28 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform

    Patent Covers the Composition of LineaRx's Proprietary Linea™ RNA Polymerase (RNAP), a Core Technology Empowering the Linea™ IVT Platform BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), announced today that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has been granted a European patent by the European Patent Office (EPO) related to European Patent Application No.: 21882234.4 (EP4232569A1) entitled "Compositions and Methods for RNA Synthesis." The European patent grant follows a U.S. patent grant in 2024 and covers the composition of LineaRx's chemically modified RNA polymerase (RNAP) enzyme branded Linea RNAP. The Company plans to validate the patent in key Europ

    3/18/26 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers

    Provides Updated on BNB Token Holdings and Operating Company Performance BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company") today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has received two new orders for LineaDNA from well-established developers of genetic medicines. Production and shipment of both orders is expected to be completed prior to June 2026. "We're pleased to receive these new orders from leading genetic medicine companies," said Clay Shorrock, President and CEO of BNBX. "We believe our continued engagements with top-tier customers demonstrates both the technical excellence of our LineaDNA platform and our continued operational execution.

    2/24/26 7:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director

    Digital Asset and Infrastructure Expert Joins Board to Support Strategic Growth and BNB Treasury Operations BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today announced the appointment of James Haft as an Independent Director and member of the Board's Nominating Committee, effective as of February 2, 2026. Mr. Haft is a recognized pioneer in digital asset investments and decentralized finance, bringing more than 35 years of experience spanning blockchain infrastructure, emerging markets, and traditional finance. Mr. Haft has served as a managing director at Bear Stearns Inc, Furman Selz and ING Barings, where he focused on emerging markets, and founded and served as chairman

    2/5/26 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    SEC Filings

    View All

    SEC Form DEF 14A filed by BNB Plus Corp.

    DEF 14A - BNB PLUS CORP. (0000744452) (Filer)

    3/24/26 4:15:13 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNB Plus Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - BNB PLUS CORP. (0000744452) (Filer)

    3/24/26 4:06:00 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    SEC Form PRE 14A filed by BNB Plus Corp.

    PRE 14A - BNB PLUS CORP. (0000744452) (Filer)

    3/12/26 5:24:23 PM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Leadership Updates

    Live Leadership Updates

    View All

    BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director

    Digital Asset and Infrastructure Expert Joins Board to Support Strategic Growth and BNB Treasury Operations BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today announced the appointment of James Haft as an Independent Director and member of the Board's Nominating Committee, effective as of February 2, 2026. Mr. Haft is a recognized pioneer in digital asset investments and decentralized finance, bringing more than 35 years of experience spanning blockchain infrastructure, emerging markets, and traditional finance. Mr. Haft has served as a managing director at Bear Stearns Inc, Furman Selz and ING Barings, where he focused on emerging markets, and founded and served as chairman

    2/5/26 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

    Rebrand Aligned with Yield-Focused BNB Treasury and BNBX Ticker Appointment Strengthens DeFi Leadership Applied DNA Sciences, Inc. (NASDAQ:BNBX) (the "Company") today announced that it will change its name to BNB Plus Corp. ("BNB Plus"), reflecting the Company's commitment to delivering a yield-optimized, BNB-based digital asset treasury strategy leveraging the Binance ecosystem. Alongside the rebrand, the Company also announced the appointment of Josh Kruger as Chairman of the Board. Mr. Kruger has deep expertise in managing blockchain-native assets for yield and capital efficiency. He is the founder of OnChain Alpha and previously served as Head of Trading at Coral Capital, which wa

    11/17/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    $BNBX
    Financials

    Live finance-specific insights

    View All

    BNB Plus Provides BNB Treasury and Operational Updates

    Company Acquires 3,349 Additional BNB Tokens LineaRx Subsidiary Expected to Narrow Losses and Approach Profitability in FY26Q1 Company Launches New Corporate Website and Branding BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the "Company"), today provided a corporate update highlighting its recent strategic treasury growth, expected significant narrowing of losses at its LineaRx, Inc. ("LineaRx") subsidiary, and the launch of a new corporate website and branding. Significant Addition to BNB Treasury The Company has opportunistically deployed an additional approximately $3 million to acquire additional BNB tokens at an average price of approximately $895 per token, further strengthening the C

    12/9/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

    Company Launches BNBX.io to Provide Robust Real-Time Portfolio and Company Metrics Company Recently Closed Up to $58 Million Private Placement to Launch Yield-Focused BNB Treasury Applied DNA Sciences, Inc. (NASDAQ:BNBX) ( "BNBX" or the "Company") today announced the launch of BNBX.io, which provides real-time portfolio metrics updating the market on the Company's BNB treasury holdings, key valuation metrics, and detailed information about the capitalization structure of the Company (the "Dashboard"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028565774/en/ "The launch of our Dashboard reflects BNBX's commitment to re

    10/28/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary

    Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

    Company Officially Launches Yield-Focused Digital Asset Treasury Strategy Streamlines Operations, Achieving Approximately $2.9 Million in Annualized Cost Savings Applied DNA Sciences, Inc. (NASDAQ:BNBX) ("Applied DNA", "BNBX" or the "Company"), a biotechnology company advancing a yield focused BNB digital asset treasury strategy and commercializing nucleic acid production solutions, today announced the successful close of its previously announced private investment in public equity ("PIPE") financing led by institutional DeFi and TradFi investors. The PIPE resulted in gross proceeds of approximately $27 Million to the Company, before deducting placement agent fees and other offering e

    10/22/25 8:00:00 AM ET
    $BNBX
    Other Consumer Services
    Consumer Discretionary